Detalhe da pesquisa
1.
Research autopsy programmes in oncology: shared experience from 14 centres across the world.
J Pathol
; 263(2): 150-165, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38551513
2.
NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer.
Breast Cancer Res
; 26(1): 69, 2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38650031
3.
Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet Oncol
; 24(2): 162-174, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36623515
4.
A phase 1 study of veliparib (ABT-888) plus weekly carboplatin and paclitaxel in advanced solid malignancies, with an expansion cohort in triple negative breast cancer (TNBC) (ETCTN 8620).
Breast Cancer Res Treat
; 198(3): 487-498, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36853577
5.
Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 21(10): 1269-1282, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32861273
6.
TBCRC 002: a phase II, randomized, open-label trial of preoperative letrozole with or without bevacizumab in postmenopausal women with newly diagnosed stage 2/3 hormone receptor-positive and HER2-negative breast cancer.
Breast Cancer Res
; 22(1): 22, 2020 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32070401
7.
Targeted mutation detection in breast cancer using MammaSeq™.
Breast Cancer Res
; 21(1): 22, 2019 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30736836
8.
Correction: NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer.
Breast Cancer Res
; 26(1): 83, 2024 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38790033
9.
Metaplastic breast carcinoma: a clinical-pathologic study of 97 cases with subset analysis of response to neoadjuvant chemotherapy.
Mod Pathol
; 32(6): 807-816, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30723293
10.
Health-related quality of life in patients receiving first-line eribulin mesylate with or without trastuzumab for locally recurrent or metastatic breast cancer.
BMC Cancer
; 19(1): 578, 2019 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31195996
11.
Erratum to Metaplastic Breast Carcinoma: A Clinical-Pathologic Study of 97 Cases With Subset Analysis of Response to Neoadjuvant Chemotherapy [Modern Pathology 32(6) (2019) 807-816].
Mod Pathol
; 36(8): 100267, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37453277
12.
Clinically Observed Estrogen Receptor Alpha Mutations within the Ligand-Binding Domain Confer Distinguishable Phenotypes.
Oncology
; 94(3): 176-189, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29306943
13.
Mutation site and context dependent effects of ESR1 mutation in genome-edited breast cancer cell models.
Breast Cancer Res
; 19(1): 60, 2017 05 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28535794
14.
Magee Equation 3 predicts pathologic response to neoadjuvant systemic chemotherapy in estrogen receptor positive, HER2 negative/equivocal breast tumors.
Mod Pathol
; 30(8): 1078-1085, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28548119
15.
A randomized Phase II study of veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in BRCA1/2 metastatic breast cancer: design and rationale.
Future Oncol
; 13(4): 307-320, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27739325
16.
Prevalence and determinants of end-of-life chemotherapy use in patients with metastatic breast cancer.
Breast J
; 23(6): 718-722, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28845536
17.
Metastatic breast cancer patients: attitudes toward tissue donation for rapid autopsy.
Breast Cancer Res Treat
; 155(1): 159-64, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26705147
18.
The molecular landscape of premenopausal breast cancer.
Breast Cancer Res
; 17: 104, 2015 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26251034
19.
TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases.
Breast Cancer Res Treat
; 146(3): 557-66, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25001612
20.
A Phase II study of bevacizumab in combination with trastuzumab and docetaxel in HER2 positive metastatic breast cancer.
Invest New Drugs
; 32(6): 1285-94, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24894652